Prior authorization delays patient medication and treatment
Prior authorization problems delayed treatment, including one GLP-1 refill that took nearly three weeks to resolve. Pharmacists and prescribers report that such delays are common.
Who it affects: Patients needing prescriptions or treatment that requires prior authorization, including GLP-1 patients
Opportunity confidence: medium. Capped at medium: the gap has evidence on both sides.
Key findings
NEEDRIX research found this problem well documented (8 evidence items from 7 independent sources); the evidence on whether existing solutions fall short points both ways. Commercial potential: plausible but unproven (sources show money spent on related help, not that people would pay for a new solution). Opportunity confidence: medium.
- Area of life
- Health care costs & paperwork
- Gap status
- Gap contested
- Evidence
- 8 items from 7 independent sources (see sources)
- Published
- Last updated
Yes (high confidence)
High: 8 evidence items from 7 independent sources show the problem is real.
Contested
5 independent sources support the gap, but 5 checked source(s) point the other way (for example, existing solutions working well for some customers). Resolve this before investing.
Plausible, but unproven
5 cited source(s) show people paying, or spending money, to deal with this problem. Spending on related help is not proof that people would pay for a new solution.
The unmet need
Patient-facing tracking and follow-up of prior authorizations after submission (including renewals/expirations for ongoing GLP-1 refills), so patients are not surprised at the pharmacy counter and stalled or pended requests get chased. Existing ePA, outsourcing and cash-pay tools mostly serve providers/pharmacies or bypass insurance rather than helping insured patients manage a stalled PA. This is a tentative gap, not confirmed.
Who is left out: Insured patients on ongoing prescriptions, especially GLP-1 users, whose prior authorization expires, is pended, or stalls and who cannot or do not want to pay cash. The sources do not show that they use any existing solution.
Why existing solutions may fall short
A GLP-1 patient's refill stalled for nearly three weeks on a PA issue, and she had to chase the insurer and PBM; the sources do not show whether any ePA tool was used or failed.
“It took Mayo nearly three weeks to sort out the prior authorization issue for her GLP-1 prescription.”
First-hand complaint · prior authorizations expiration prescription insurance
A patient asks why she needs a new PA when she is already authorized, which suggests expirations and renewals are opaque to patients.
“Why do I need a prior authorization for something that I am already prior authorized to take?”
First-hand complaint · prior authorizations expiration prescription insurance
Even where ePA exists, a pended request still delays the patient unless staff follow up. This points to a post-submission follow-up gap.
“if an ePA request is pended, the patient still faces delay unless there is efficient follow-up by staff.”
Company's own description · ePA Explained: NCPDP SCRIPT & Surescripts Prior Authorization
Patients in a GLP-1 obesity-care survey described PA delay as a process failure and most wanted all-in-one tracking of refills, PA and appointments, which indicates unmet patient-facing demand.
“The most desired digital features were all-in-one tracking of refills, prior authorization, and appointments (89.5%)”
Official / independent report · Patient-Reported Continuity of GLP-1 Receptor Agonist Therapy - PubMed
Patients usually learn about a PA requirement only at the pharmacy counter, so the existing flow does not inform them upfront.
“patients typically find out at the pharmacy that the drug is not covered or requires a prior authorization.”
Official / independent report · Electronic Prior Authorization is Catching on
A health system reports GLP-1 PAs taking about 8 weeks, which shows delays persist for this segment despite existing tools.
“prior authorizations are currently taking approximately 8 weeks to complete.”
Official / independent report · Important Information About Weight Loss GLP-1 Medication Prior Authorizations
Each quote was checked word for word against the stored source. Inferences are not shown as evidence.
What would disprove this opportunity
Evidence already found against it
CoverMyMeds describes many ePA requests receiving auto-determinations and immediate decisions, so the need is partly met on the provider side.
“many ePA requests through CoverMyMeds received auto-determinations, allowing for immediate di”
Company's own description · Overcoming Medication Access Barriers Caused by Prior Authorization
Surescripts says its automation sharply cuts approval time, though this is a vendor claim.
“prior authorization approvals for in-scope medications previously took an average of over 71 minutes.”
Company's own description · Prior Authorization Automation
Cash-pay routes avoid PA entirely, so some GLP-1 patients already have a workaround.
“cash-pay purchases don't require prior authorization from an insurer.”
Company's own description · GLP-1 Cost & Insurance 2026: What You Pay (MD-Reviewed)
Outsourced PA services are cheap and already serve providers, so provider-side labor is well covered.
“Per-auth pricing starts at $4 to $8.”
Company's own description · Top Prior Authorization Outsourcing Services
AI PA tools report high first-pass approval rates, though these are vendor claims.
“Optum’s Digital Auth Complete reports a 96% first-pass approval rate.”
Company's own description · Best AI Prior Authorization Tools for Medical Clinics
What we don't know yet
- Whether any existing tool offers patients PA status tracking or expiration reminders; the sources do not say.
- Whether patients would pay for a patient-facing tool, and how they would be reached.
- Whether PBM and insurer data are accessible to a third-party patient app.
- How often PA expirations, as opposed to initial denials, cause the delays.
- Whether the Mayo case involved any ePA tool.
- The size of the insured GLP-1 segment that cannot use cash pay.
- Whether the 89.5% survey result reflects real willingness to adopt, given the 5.3% response rate.
- Market size: unknown. No source in this research measures how many people would buy.
- Build feasibility: NEEDRIX's own estimate, not proven by a source.
Tests that would prove it wrong
- Check whether CoverMyMeds, Surescripts, or insurer and pharmacy apps already give patients PA status and expiration alerts.
- Interview 15-20 insured GLP-1 patients with PA delays to see whether they would use or pay for a tracker and what they tried before.
- Test whether a patient-facing tool can legally and technically get PA status from PBMs and payers.
- Measure what share of PA delays come from expirations or pended requests rather than clinic-side submission lag; if small, the gap is weak.
- Run a landing-page or concierge pilot and check whether patients sign up and whether it shortens resolution time against a control.
Existing solutions we found
Electronic prior authorization platform used by providers; many requests get auto-determinations and quick dispensing.
Where it may fall short: Sold to providers, not patients. Pended or complex cases still stall, and half of PA volume was reported to still go by phone/fax in a dated 2020 report.
Surescripts Prior Authorization Automation
Automates PA for in-scope medications; vendor says approvals used to take over 71 minutes on average.
Where it may fall short: Provider-side product covering only in-scope medications. Speed figures are vendor claims, and patients still lack visibility.
Outsourced PA staff for practices, listed from $399/wk per specialist or $4-$8 per authorization.
Where it may fall short: Serves practices, not patients. Patients cannot buy it to chase their own case.
Prior authorization services for healthcare providers, advertised at $7/hr.
Where it may fall short: B2B revenue-cycle service; no patient-facing tracking or help.
LillyDirect / NovoCare cash-pay (GLP-1 workaround)
Manufacturer self-pay GLP-1 pricing that bypasses insurer PA, e.g. Zepbound vials from $299/month.
Where it may fall short: Costly out of pocket, cannot be combined with insurance, a prescription is still needed, and it only helps GLP-1 patients.
Telehealth cash-pay GLP-1 clinics
Compounded or branded GLP-1 via telehealth, often low hundreds of dollars per month.
Where it may fall short: Does not fix PA for other drugs or treatments; compounded products are not FDA-approved; costs are ongoing.
Descriptions summarize public pages and may be incomplete. Follow the links for each company's own information.
Signs of spending on related help
This shows money spent around the problem. It is not proof that people would pay for a new solution.
A telehealth clinic page claims most GLP-1 patients pay out of pocket, by choice or because insurance was denied or delayed (seller claim, not independent data).
GLP-1 Medications Without Insurance (rivasweightloss.com)
Practices pay for PA outsourcing, e.g. from $399/week per specialist or $4-$8 per authorization.
Top Prior Authorization Outsourcing Services (staffingly.com)
In-house PA coordinators cost $45,000-$60,000/year in salary alone.
Prior Authorization Services for Healthcare Providers: What to Know in 2026 (staffingly.com)
89.5% of respondents most desired all-in-one digital tracking of refills, prior authorization and appointments (desire, not payment).
Patient-Reported Continuity of GLP-1 Receptor Agonist Therapy - PubMed (pubmed.ncbi.nlm.nih.gov)
Patients can pay for cash-pay GLP-1 to avoid PA, e.g. Zepbound vials $299-$449/month per one guide.
GLP-1 Medication Pricing Guide — Wegovy, Zepbound, Ozempic & Mounjaro (peakwellnessva.com)
Sources: what people reported
“showed delays to care (with most delays ≥2 weeks), increased anxiety”
The Patient Experience of Prior Authorization for Cancer Care (ncbi.nlm.nih.gov)
Short excerpt returned by web search. One person's account; not independently verified.
“More than nine in 10 physicians (95%) say prior authorization delays access to necessary care.”
AMA survey: Prior authorization reform pledge falls short with physicians (ama-assn.org) · published 2026-05-14
Short excerpt returned by web search. One person's account; not independently verified.
“prior authorizations are currently taking approximately 8 weeks to complete.”
Important Information About Weight Loss GLP-1 Medication Prior Authorizations (southcoast.org)
Short excerpt returned by web search. One person's account; not independently verified.
“The most desired digital features were all-in-one tracking of refills, prior authorization, and appointments (89.5%)”
Patient-Reported Continuity of GLP-1 Receptor Agonist Therapy - PubMed (pubmed.ncbi.nlm.nih.gov) · published 2026-09-01
Short excerpt returned by web search. One person's account; not independently verified.
“31% reported back-and-forth with their health plan, provider or pharmacy just to get their prescription moving.”
5 Barriers to Patient Medication Access (surescripts.com) · published 2026-10-21
Short excerpt returned by web search. One person's account; not independently verified.
“13% of patients report that their health actually worsened because of delays”
2026 Survey: Patient Challenges in Healthcare (surescripts.com) · published 2026-06-17
Short excerpt returned by web search. One person's account; not independently verified.
“88% of pharmacists and 70% of prescribers said the process often or always delays treatment for patients.”
www.businesswire.com (businesswire.com)
Short excerpt returned by web search. One person's account; not independently verified.
“Why do I need a prior authorization for something that I am already prior authorized to take?”
prior authorizations expiration prescription insurance (npr.org)
Short excerpt returned by web search. One person's account; not independently verified.
“It took Mayo nearly three weeks to sort out the prior authorization issue for her GLP-1 prescription.”
prior authorizations expiration prescription insurance (npr.org)
Short excerpt returned by web search. One person's account; not independently verified.
“It took Mayo nearly three weeks to sort out the prior authorization issue for her GLP-1 prescription.”
prior authorizations expiration prescription insurance (npr.org)
Short excerpt returned by web search. One person's account; not independently verified.
Related discoveries
Airlines mishandle and damage passengers' wheelchairs and scooters
U.S. airlines mishandle wheelchairs and scooters at a reported rate of about 1 in 100, leaving travelers with damaged mobility devices, including one wheelchair that would not start after landing. Passengers also reportedly wait weeks or more for repair or replacement.
Problem: real (medium evidence)Gap contestedCommercial: plausible, unprovenOpportunity confidence: medium
How to cite this research
NEEDRIX. “Prior authorization delays patient medication and treatment.” Updated 2026-11-06. https://needrix.com/discoveries/13-prior-authorization-delays-patient-medication-and-treatment. Please include the gap status (gap contested).
Last updated 2026-11-06. Quotes are short excerpts from public pages, kept so you can check our work; follow each link for the full context. Research findings are not advice and not a prediction of commercial success. Report an error.